HOUSTON - A Houston research firm has been selected for COVID-19 vaccine trials.
The Texas Center for Drug Development, or TCDD, is looking for volunteers in the trials that will be underway in a couple of weeks.
The program is a joint initiative between DM Clinical Research and TCDD—two of the largest non-institutional clinical research
networks in greater Houston—and will be conducted under the careful medical supervision of their research physicians.
According to a press release, these investigational vaccines have been given the nod by the FDA for Phase 2 and Phase 3 trials.
TCDD says participants in the study will not be injected with the actual virus.
“I’m eager to work on resolving the public health crisis caused by COVID-19," says Dr. Vicki Miller of TCDD. "From here in Houston at our research sites to the companies developing new treatments and vaccines, it’s a collaborative effort between everyone.”